John Griffin (Trades, Portfolio), president of Blue Ridge Capital, made five new buys in the fourth quarter, three of which had impacts on his portfolio exceeding 1.5%.
Griffin’s most significant fourth-quarter transaction was his purchase of a 4 million-share stake in Teva Pharmaceutical Industries Ltd. (TEVA, Financial), an Israeli pharmaceutical company, for an average price of $61.94 per share. The deal had a 2.92% impact on Griffin’s portfolio.
Griffin’s stake is 0.44% of Teva Pharmaceutical’s outstanding shares and 2.92% of Griffin’s total assets. Andreas Halvorsen (Trades, Portfolio) is Teva Pharmaceutical’s leading shareholder among the gurus with a stake of 25,043,775 shares. The stake is 2.76% of the company’s outstanding shares and 6.2% of Halvorsen’s total assets.
Teva Pharmaceutical has a P/E of 30.8, a forward P/E of 9.1, a P/B of 1.9 and a P/S of 2.5. GuruFocus gives Teva Pharmaceutical a Financial Strength rating of 7/10 and a Profitability and Growth rating of 7/10.
Teva Pharmaceutical sold for $56.36 per share Wednesday.
Griffin invested in a 1.17 million-share stake in Canadian Pacific Railway Ltd. (CP, Financial), the Calgary, Alberta-based parent company of Canadian Pacific Railway, for an average price of $140.24 per share. The transaction had a 1.66% impact on Griffin’s portfolio.
Griffin’s stake is 0.76% of the company’s outstanding shares and 1.66% of Griffin’s total assets. Bill Ackman (Trades, Portfolio) is Canadian Pacific Railway’s leading shareholder among the gurus with a stake of 13,940,890 shares. The stake is 9.11% of the company’s outstanding shares and 14.28% of Ackman’s total assets.
Canadian Pacific Railway has a P/E of 18.1, a forward P/E of 13.3, a P/B of 5.2 and a P/S of 4. GuruFocus gives Canadian Pacific Railway a Financial Strength rating of 7/10 and a Profitability and Growth rating of 7/10.
Canadian Pacific Railway sold for $119.95 per share Wednesday.
Griffin acquired a 1,815,000-share stake in Dollar Tree Stores Inc. (DLTR, Financial), a Chesapeake, Virginia-based chain of discount variety stores, for an average price of $70.15 per share. The deal had a 1.56% impact on Griffin’s portfolio.
Griffin’s stake is 0.77% of Dollar Tree Stores’ outstanding shares and 1.56% of Griffin’s total assets. Steve Mandel (Trades, Portfolio) is Dollar Tree Stores’ leading shareholder among the gurus with a stake of 13,194,122 shares. The stake is 5.62% of the company’s outstanding shares and 4.35% of the guru’s total assets.
Dollar Tree Stores has a P/E of 64.1, a forward P/E of 21.8, a P/B of 4.4 and a P/S of 1.4. GuruFocus gives Dollar Tree Stores a Financial Strength rating of 6/10 and a Profitability and Growth rating of 8/10.
Dollar Tree Stores sold for $78.77 per share Wednesday.
Griffin raised his stake in Autodesk Inc. (ADSK, Financial), a San Rafael, California-based computer software company, by nearly 45%. Griffin purchased 3.08 million shares for an average price of $58.45 per share, boosting his stake to 10 million shares. The transaction had a 2.09% impact on Griffin’s portfolio.
Griffin’s stake is 4.44% of the company’s outstanding shares and 6.78% Griffin’s total assets. Griffin is Autodesk’s leading shareholder among the gurus.
Autodesk has a forward P/E of 102, a P/B of 7.6 and a P/S of 4.9. GuruFocus gives Autodesk a Financial Strength rating of 4/10 and a Profitability and Growth rating of 7/10.
Autodesk sold for $54.41 per share Wednesday.
Griffin increased his stake in Allergan PLC (AGN, Financial), a pharmaceutical company with offices in Dublin and New Jersey, by almost 23%. Griffin bought 369,158 shares for an average price of $298.52 per share. The deal had a 1.28% impact on Griffin’s portfolio.
Griffin’s stake, now 2 million shares, is 0.51% of Allergan’s outstanding shares and 6.96% of the guru’s total assets. Vanguard Health Care Fund (Trades, Portfolio) is Allergan’s leading shareholder among the gurus with a stake of 10,962,347 shares. The stake is 2.78% of Allergan’s outstanding shares and 6.81% of Vanguard’s total assets.
Allergan has a P/E of 38.5, a forward P/E of 15.5, a P/B of 1.5 and a P/S of 7.2. GuruFocus gives Allergan a Financial Strength rating of 6/10 and a Profitability and Growth rating of 7/10.
Allergan sold for $292.48 per share Wednesday.
Griffin sold his 1,015,000-share stake in Illumina Inc. (ILMN, Financial), a San Diego-based biotechnology company, for an average price of $166.62 per share. The divestiture had a -2.05% impact on Griffin’s portfolio.
Frank Sands (Trades, Portfolio) is Illumina’s leading shareholder among the gurus with 6,091,448 shares in his portfolio. The stake is 4.16% of Illumina’s outstanding shares and 3.01% of Sands’ total assets.
Illumina has a P/E of 45.8, a forward P/E of 38.6, a P/B of 12.5 and a P/S of 10.9. GuruFocus gives Illumina a Financial Strength rating of 8/10 and a Profitability and Growth rating of 9/10.
Illumina sold for $157.2 per share Wednesday.
Griffin sold his 2,595,000-share stake in Post Holdings Inc. (POST, Financial), a St. Louis-based consumer packaged goods holding company, for an average price of $63.39 per share. The deal had a -1.77% impact on Griffin’s portfolio.
Post Holdings’ leading shareholder among the gurus is John Paulson (Trades, Portfolio) with a stake of 4,104,800 shares. The stake is 6.4% of the company’s outstanding shares and 1.56% of Paulson’s total assets.
Post Holdings has a forward P/E of 40.8, a P/B of 1.5 and a P/S of 0.9. GuruFocus gives Post Holdings a Financial Strength rating of 7/10 and a Profitability and Growth rating of 7/10.
Post Holdings sold for $71.49 per share Wednesday.
Griffin sold his 2,375,000-share stake in Alibaba Group Holding Ltd. (BABA, Financial), a Chinese ecommerce company, for an average price of $78.9 per share. The divestiture had a -1.61% impact on Griffin’s portfolio.
Alibaba Group’s leading shareholder among the gurus is Louis Moore Bacon (Trades, Portfolio) with a stake of 815,000 shares in his portfolio. The stake is 0.03% of Alibaba Group’s outstanding shares and 2.06% of Bacon’s total assets.
Alibaba Group has a P/E of 12.7, a forward P/E of 20.5, a P/B of 5.5 and a P/S of 12.7. GuruFocus gives Alibaba Group a Financial Strength rating of 6/10 and a Profitability and Growth rating of 6/10.
Alibaba Group sold for $71.25 per share Wednesday.
Griffin sold his 1.09 million-share stake in Thermo Fisher Scientific Inc. (TMO, Financial), a Waltham, Massachusetts-based laboratory equipment company, for an average price of $133.76 per share. The divestiture had a -1.53% impact on Griffin’s portfolio.
Larry Robbins (Trades, Portfolio) is Thermo Fisher’s leading shareholder among the gurus with a stake of 5,933,331 shares. The stake is 1.5% of the company’s outstanding shares and 4.74% of Robbins’ total assets.
Thermo Fisher has a P/E of 28.1, a forward P/E of 15.2, a P/B of 2.5 and a P/S of 3.2. GuruFocus gives Thermo Fisher a Financial Strength rating of 7/10 and a Profitability and Growth rating of 9/10.
Thermo Fisher sold for $138.12 per share Wednesday.
Griffin sold his 1.47 million-share stake in Workday Inc. (WDAY, Financial), a Pleasanton, California-based financial management and human capital management software vendor, for an average price of $80.15 per share. The transaction had a -1.17% impact on Griffin’s portfolio.
Workday’s leading shareholder among the gurus is Sands with a stake of 5,745,060 shares in his portfolio. The stake is 2.96% of Workday’s outstanding shares and 1.18% of Sands’ total assets.
Workday has a P/B of 12.3 and a P/S of 12.7. GuruFocus gives Workday a Financial Strength rating of 9/10 and a Profitability and Growth rating of 4/10.
Workday sold for $71.91 per share Wednesday.
Griffin reduced his stake in Endo International PLC (ENDP, Financial), a health care company with offices in Dublin and Pennsylvania, by more than 51%. Griffin sold 2.15 million shares for an average price of $60.66 per share. The deal had a -1.71% impact on Griffin’s portfolio.
Griffin’s remaining stake of 2.05 million shares is 0.92% of Endo’s outstanding shares and 1.4% of Griffin’s total assets. Endo’s leading shareholder among the gurus is Halvorsen with a stake of 4,520,954 shares. The stake is 2.03% of the company’s outstanding shares and 1.04% of Halvorsen’s total assets.
Endo has a forward P/E of 6, a P/B of 1.5 and a P/S of 2.3. GuruFocus gives Endo a Financial Strength rating of 5/10 and a Profitability and Growth rating of 6/10.
Endo sold for $43.85 per share Wednesday.
Griffin reduced his stake in Sirius XM Holdings Inc. (SIRI), a New York-based satellite radio broadcasting company, by more than 44%. Griffin sold 24,195,000 shares for an average price of $4.05 per share, leaving him with a stake of 30.7 million. The transaction had a -1.04% impact on Griffin’s portfolio.
Griffin’s stake is 0.59% of Sirius XM’s outstanding shares and 1.39% of Griffin’s total assets. Leon Cooperman (Trades, Portfolio) is Sirius XM’s leading shareholder among the gurus with a stake of 32,153,846 shares. The stake is 0.62% of the company’s outstanding shares and 2.86% of Cooperman’s total assets.
Sirius XM has a P/E of 38.2, a forward P/E of 19.3 and a P/S of 4.5. GuruFocus gives Sirius XM a Financial Strength rating of 7/10 and a Profitability and Growth rating of 8/10.
Sirius XM sold for $3.82 per share Wednesday.
To view the portfolios of more gurus, visit the List of Gurus page. Not a premium member of GuruFocus? Try it free for 7 days.
